Kopp Family Office’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-40,614
Closed -$3.01M 25
2025
Q3
$3.01M Hold
40,614
1.96% 18
2025
Q2
$5.27M Sell
40,614
-427
-1% -$61.9K 3.41% 12
2025
Q1
$6.54M Hold
41,041
4.52% 10
2024
Q4
$7.61M Sell
41,041
-24
-0.1% -$4.66K 4.82% 10
2024
Q3
$8.67M Hold
41,065
5.52% 9
2024
Q2
$5.5M Buy
41,065
+11
+0% +$2.08K 3.41% 11
2024
Q1
$8.82M Buy
41,054
+7,829
+24% +$1.53M 5.04% 8
2023
Q4
$6.76M Buy
33,225
+15,113
+83% +$2.45M 3.95% 10
2023
Q3
$3.59M Hold
18,112
2.27% 11
2023
Q2
$5.88M Buy
18,112
+3,877
+27% +$1.11M 3.16% 11
2023
Q1
$3.33M Buy
14,235
+7,258
+104% +$1.83M 1.8% 13
2022
Q4
$1.76M Buy
+6,977
New +$1.49M 1.06% 13

Other funds holding INSP

Kopp Family Office's INSP Position: Q4 2025 in Review

Kopp Family Office sold out of Inspire Medical Systems (INSP) in Q4 2025, closing a stake of 40,614 shares — an estimated $3.01M sold.

Kopp Family Office first reported a position in INSP in Q4 2022 and held it in 12 quarters. The position peaked at $8.82M in Q1 2024. 342 funds tracked by Wall St. Rank hold INSP as of Q4 2025.

  • Kopp Family Office reported no remaining Inspire Medical Systems position as of Q4 2025 after selling out during the quarter.
  • Kopp Family Office sold 40,614 Inspire Medical Systems shares in Q4 2025, an estimated $3.01M.
  • Kopp Family Office first reported a position in Inspire Medical Systems in Q4 2022 and held it in 12 quarters.
  • Kopp Family Office's Inspire Medical Systems position peaked at $8.82M in Q1 2024.
  • 342 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q4 2025.

Based on Kopp Family Office's 13F filing for Q4 2025, filed 12 Jan 2026.